Uterine artery embolization
Minimally invasive procedure to treat fibroids
Uterine artery embolization (UAE) is a minimally invasive procedure used to treat uterine fibroids, which are non-cancerous growths in the uterus. The procedure involves blocking the blood supply to the fibroids, causing them to shrink and die.
Procedure[edit]
Uterine artery embolization is performed by an interventional radiologist. The procedure begins with the insertion of a catheter into the femoral artery in the groin. Using fluoroscopy, the catheter is guided to the uterine arteries. Once in place, small particles are injected to block the blood flow to the fibroids. This process is known as embolization.

The particles used in UAE are typically made of polyvinyl alcohol or other biocompatible materials. These particles lodge in the small blood vessels that supply the fibroids, effectively cutting off their blood supply. Over time, the fibroids shrink and symptoms improve.
Indications[edit]
Uterine artery embolization is primarily indicated for women who experience significant symptoms from fibroids, such as heavy menstrual bleeding, pelvic pain, or pressure symptoms. It is an alternative to surgical options like hysterectomy or myomectomy.
Benefits and Risks[edit]
The benefits of UAE include a shorter recovery time compared to surgical options, preservation of the uterus, and a high success rate in symptom relief. However, there are risks associated with the procedure, including infection, pain, and potential impacts on future fertility.
Recovery[edit]
Recovery from uterine artery embolization typically involves a short hospital stay, followed by a few days of rest at home. Most women can return to normal activities within one to two weeks. Pain and cramping are common in the first few days after the procedure and can be managed with medication.
Outcomes[edit]
Studies have shown that UAE is effective in reducing fibroid size and alleviating symptoms in the majority of patients. Long-term outcomes are generally positive, with many women experiencing significant improvement in quality of life.

Related pages[edit]
References[edit]

Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian